Get the Stockscreener App
701.02
0.92%
-6.48
Idexx Laboratories Inc stock is traded at $701.02, with a volume of 174.58K.
It is down -0.92% in the last 24 hours and down -1.76% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
See More
Previous Close:
$707.50
Open:
$710.46
24h Volume:
174.58K
Relative Volume:
0.34
Market Cap:
$55.98B
Revenue:
$4.17B
Net Income/Loss:
$1.03B
P/E Ratio:
55.57
EPS:
12.6148
Net Cash Flow:
$940.22M
1W Performance:
-1.83%
1M Performance:
-1.76%
6M Performance:
+33.04%
1Y Performance:
+60.35%
1-Day Range:
$699.15
$715.19
1-Week Range:
$693.72
$721.50
52-Week Range:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
701.02 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
573.39 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
229.05 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
140.85 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
223.24 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Oct-31-25 | Upgrade | Stifel | Hold → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
$1000 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today - Benzinga
IDEXX (NASDAQ:IDXX) Nasdaq Futures Capture Rising Clinical Demand - Kalkine Media
Resistance Check: Will IDEXX Laboratories Inc stock deliver consistent dividendsWeekly Risk Summary & Advanced Technical Signal Analysis - BỘ NỘI VỤ
Barclays Initiates Coverage of IDEXX Laboratories (IDXX) with Overweight Recommendation - Nasdaq
Barclays Initiates Coverage on IDEXX Laboratories (IDXX) with Ov - GuruFocus
Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $850 - 富途牛牛
iSAM Funds UK Ltd Takes $1.85 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Barclays Initiates IDEXX Laboratories With Overweight Rating, $850 Price Target - marketscreener.com
Ossiam Grows Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Purchased by California Public Employees Retirement System - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch
How is IDEXX Laboratories’ stock performance compared to other health care stocks? - MSN
Mirabella Financial Services LLP Sells 4,783 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Guggenheim Capital LLC Purchases 3,577 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
First Trust Advisors LP Purchases 35,526 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Edgestream Partners L.P. Has $1.48 Million Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Brown Advisory Inc. Sells 10,408 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Amundi Has $366.69 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
At US$717, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely? - Yahoo Finance
Can IDEXX Laboratories Inc. stock continue upward trendEarnings Overview Summary & Low Volatility Stock Suggestions - Newser
Epoch Investment Partners Inc. Has $134.40 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Can IDEXX Laboratories Inc. (IX1) stock stage a strong rebound this quarterPortfolio Performance Summary & Real-Time Sentiment Analysis - Newser
IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge? - The Globe and Mail
Why IDEXX Laboratories Inc. (IX1) stock stays undervaluedJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser
Invesco Ltd. Has $621.34 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Can IDEXX Laboratories Inc. stock resist sector downturns2025 Top Decliners & Verified Stock Trade Ideas - Newser
Should I hold or sell IDEXX Laboratories Inc. stock in 2025Portfolio Growth Summary & Weekly Chart Analysis and Trade Guides - Newser
Arrowstreet Capital Limited Partnership Acquires 15,227 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
How Is IDEXX Laboratories’ Stock Performance Compared to Other Health Care Stocks? - Barchart.com
Idexx (IDXX) Up 1.5% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Norges Bank Invests $221.96 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Granite Investment Partners LLC Has $2.06 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
D L Carlson Investment Group Inc. Buys New Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Is IDEXX Laboratories Inc. (IX1) stock worth buying before Fed action2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Veterinary Software Market Set to Witness Significant Growth by 2025-2032 | Idexx Laboratories, Covetrus Inc., - EIN News
New York State Common Retirement Fund Sells 24,581 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Will IDEXX Laboratories Inc. (IX1) stock extend growth storyQuarterly Portfolio Report & Technical Confirmation Alerts - Newser
If You Invested $1000 in Idexx Laboratories 10 Years Ago, This Is How Much You'd Have Now - sharewise.com
Idexx Labs Poised to Benefit From Adoption of InVue Cellular Analyzer - Morningstar
Railway Pension Investments Ltd Sells 10,800 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Mackenzie Financial Corp - MarketBeat
Schroder Investment Management Group Has $169.37 Million Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Purchased by Skandinaviska Enskilda Banken AB publ - MarketBeat
Steward Partners Investment Advisory LLC Has $2.07 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Grandeur Peak Global Advisors LLC Has $2.59 Million Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Capital Counsel LLC NY Sells 6,239 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Capital Fund Management S.A. Sells 8,714 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Bought by Choreo LLC - MarketBeat
Boston Family Office LLC Trims Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Advisors Asset Management Inc. Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):